Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
adenosine (Adenocard) (1 trial)
regadenoson (lexiscan) (1 trial)
Coronary Artery Disease (Phase 3)
Coronary Disease (Phase 3)
Myocardial Ischemia (Phase 3)
Trials (1 total)
Trial APIs (2 total)